2026-2034年全球鹽酸二甲雙胍市場規模、佔有率、趨勢與成長分析報告

預計鹽酸二甲雙胍市場將從 2025 年的 266.9 億美元成長到 2034 年的 495.7 億美元，2026 年至 2034 年的複合年成長率為 7.12%。

過去十年，全球鹽酸二甲雙胍市場持續成長。這一成長主要歸因於全球第2型糖尿病患者人數的不斷增加。城市生活方式、不健康的飲食習慣以及缺乏運動是糖尿病病例增加的主要原因，尤其是在開發中國家。二甲雙胍是治療糖尿病最常用且價格適中的藥物之一，因此在已開發市場和新興市場都有強勁的需求。

推動市場擴張的關鍵因素很多。人們對糖尿病早期診斷的認知不斷提高，醫療保健服務的可近性日益改善，以及政府推出的慢性病管理項目，都促使處方箋增加。此外，人口老化也推高了市場需求，因為老年人罹患糖尿病的風險更高。學名藥生產商也發揮著至關重要的作用，他們提供價格實惠、在醫院和藥房廣泛供應的產品。

預計未來市場將保持穩定成長。聯合治療和緩釋製劑的研究有望創造新的機會。亞洲、非洲和拉丁美洲醫療保險覆蓋範圍的擴大有望改善患者的用藥可及性。然而，價格壓力和嚴格的監管標準可能會給生產商帶來挑戰。總體而言，對糖尿病治療的強勁需求將支撐市場的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球鹽酸二甲雙胍市場：依產品類型分類

• 市場分析、洞察與預測
• Metformin Hydrochloride
• 二甲雙胍
• 其他

第5章 全球鹽酸二甲雙胍市場：依應用分類

• 市場分析、洞察與預測
• 速釋片
• 緩釋片

第6章：全球鹽酸二甲雙胍市場：依分銷管道分類

• 市場分析、洞察與預測
• 醫院藥房
• 零售藥房
• 網路藥房

第7章 全球鹽酸二甲雙胍市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Exemed Pharmaceuticals
  • Keyuan Pharmaceutical
  • Shouguang Fukang Pharmaceutical
  • Harman Finochem
  • Wanbury
  • Shijiazhuang Polee Pharmaceutical
  • Farmhispania Group
  • USV
  • CR Double-Crane
  • Vistin Pharma
  • Aarti Drugs

The Metformin Hydrochloride Market size is expected to reach USD 49.57 Billion in 2034 from USD 26.69 Billion (2025) growing at a CAGR of 7.12% during 2026-2034.

The global metformin hydrochloride market has grown steadily over the past decade. This growth is mainly due to the rising number of people with type 2 diabetes across the world. Urban lifestyles, unhealthy eating habits, and low physical activity have increased diabetes cases, especially in developing countries. As metformin is one of the most commonly prescribed and affordable medicines for diabetes, demand has remained strong in both developed and emerging markets.

Several key drivers support this market's expansion. Growing awareness about early diabetes diagnosis, better healthcare access, and government programs for chronic disease management have increased prescriptions. In addition, the aging population is more likely to develop diabetes, which further boosts demand. Generic drug manufacturers also play an important role by offering cost-effective versions, making the drug widely available in hospitals and pharmacies.

In the future, the market is expected to continue growing at a stable rate. Research on combination therapies and extended-release formulations may create new opportunities. Expanding healthcare coverage in Asia, Africa, and Latin America will likely increase patient access. However, price pressure and strict regulatory standards may challenge manufacturers. Overall, strong demand for diabetes treatment will support long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Metformin HCL
• Metformin DC
• Others

By Application

• Immediate Release
• Extended Release

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

COMPANIES PROFILED

• Exemed Pharmaceuticals, Keyuan Pharmaceutical, Shouguang Fukang Pharmaceutical, Harman Finochem, Wanbury, Shijiazhuang Polee Pharmaceutical, Farmhispania Group, USV, CR DoubleCrane, Vistin Pharma, Aarti Drugs
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL METFORMIN HYDROCHLORIDE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and Kilo Tons)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Metformin HCL Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 4.3. Metformin DC Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 5. GLOBAL METFORMIN HYDROCHLORIDE MARKET: BY APPLICATION 2022-2034 (USD MN and Kilo Tons)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Immediate Release Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 5.3. Extended Release Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 6. GLOBAL METFORMIN HYDROCHLORIDE MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN and Kilo Tons)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 6.3. Retail Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 6.4. Online Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 7. GLOBAL METFORMIN HYDROCHLORIDE MARKET: BY REGION 2022-2034(USD MN and Kilo Tons)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL METFORMIN HYDROCHLORIDE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Exemed Pharmaceuticals
  • 9.2.2 Keyuan Pharmaceutical
  • 9.2.3 Shouguang Fukang Pharmaceutical
  • 9.2.4 Harman Finochem
  • 9.2.5 Wanbury
  • 9.2.6 Shijiazhuang Polee Pharmaceutical
  • 9.2.7 Farmhispania Group
  • 9.2.8 USV
  • 9.2.9 CR Double-Crane
  • 9.2.10 Vistin Pharma
  • 9.2.11 Aarti Drugs